Biohaven Ltd. (BHVN) — Financial statements
Income statement, balance sheet, and cash flow for Biohaven Ltd. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 4 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -4 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 635↓20.2% | 796↑113.2% | 373↓14.6% | 437↑140.8% | 181 | |
| General & Administrative Expenses | 106↑19.0% | 89↑42.2% | 63↓52.0% | 131↑249.8% | 37 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 106↑19.0% | 89↑42.2% | 63↓52.0% | 131↑249.8% | 37 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 741↓16.3% | 885↑103.0% | 436↓23.2% | 568↑159.4% | 219 | |
| Total Costs & Expenses | 745↓15.8% | 885↑103.0% | 436↓23.2% | 568↑159.4% | 219 | |
| Operating Results | ||||||
| Operating Income | -745↑15.8% | -885↓103.0% | -436↑23.2% | -568↓159.4% | -219 | |
| Depreciation & Amortization | 10↑26.3% | 8↑13.6% | 7↑398.7% | 1↓0.5% | 1 | |
| EBITDA | -727↑17.1% | -877↓104.4% | -429↑24.3% | -567↓160.5% | -218 | |
| EBIT | -737↑16.7% | -885↓103.0% | -436↑23.2% | -568↓159.4% | -219 | |
| Interest & Other Income | ||||||
| Net Interest Income | 15↓31.6% | 21↑20.4% | 18 | 0.00 | 0.00 | |
| Interest Income | 15↓31.6% | 21↑20.4% | 18 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | -8 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 8↓79.7% | 39↑48.8% | 27↑1488.2% | -2↓129.5% | 6 | |
| Income Before Tax | -737↑12.8% | -846↓106.5% | -410↑28.1% | -570↓168.2% | -212 | |
| Income Tax Expense | 1↑96.2% | 0.74↑153.1% | -1↓415.8% | 0.44↓67.9% | 1 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -739↑12.7% | -846↓107.4% | -408↑28.4% | -570↓166.7% | -214 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -739↑12.7% | -846↓107.4% | -408↑28.4% | -570↓166.7% | -214 | |
| Bottom-Line Net Income | -739↑12.7% | -846↓107.4% | -408↑28.4% | -570↓166.7% | -214 | |
| EPS (Basic) | -6.86↑26.1% | -9.28↓62.0% | -5.73↑55.1% | -12.75↓113.6% | -5.97 | |
| EPS (Diluted) | -6.86↑26.1% | -9.28↓62.0% | -5.73↑55.1% | -12.75↓113.6% | -5.97 | |
| Weighted Average Shares | 108↑18.0% | 91↑28.1% | 71↑59.1% | 45↑24.9% | 36 | |
| Weighted Average Diluted Shares | 108↑18.0% | 91↑28.1% | 71↑59.1% | 45↑24.9% | 36 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.